AAAAAA

   
Results: 1-7 |
Results: 7
SIGNIFICANTLY HIGHER PLASMA HALOPERIDOL LEVEL DURING COTREATMENT WITHCARBAMAZEPINE MAY HERALD CARDIAC CHANGE - RESPONSE
Authors: ZUIDERWIJK PBM LAVRIJSEN K
Citation: Pbm. Zuiderwijk et K. Lavrijsen, SIGNIFICANTLY HIGHER PLASMA HALOPERIDOL LEVEL DURING COTREATMENT WITHCARBAMAZEPINE MAY HERALD CARDIAC CHANGE - RESPONSE, Clinical neuropharmacology, 20(2), 1997, pp. 179-179
MEIC EVALUATION OF ACUTE SYSTEMIC TOXICITY .1. METHODOLOGY OF 68 IN-VITRO TOXICITY ASSAYS USED TO TEST THE FIRST 30 REFERENCE CHEMICALS
Authors: CLEMEDSON C MCFARLANEABDULLA E ANDERSSON M BARILE FA CALLEJA MC CHESNE C CLOTHIER R COTTIN M CURREN R SZOLGAY ED DIERICKX P FERRO M FISKESJO G GARZAOCANAS L GOMEZLECHON MJ GULDEN M ISOMAA B JANUS J JUDGE P KAHRU A KEMP RB KERSZMAN G KRISTEN U KUNIMOTO M KARENLAMPI S LAVRIJSEN K LEWAN L LILIUS H OHNO T PERSOONE G ROGUET R ROMERT L SAWYER TW SEIBERT H SHRIVASTAVA R STAMMATI A TANAKA N TORRESALANIS O VOSS JU WAKURI S WALUM E WANG XH ZUCCO F EKWALL B
Citation: C. Clemedson et al., MEIC EVALUATION OF ACUTE SYSTEMIC TOXICITY .1. METHODOLOGY OF 68 IN-VITRO TOXICITY ASSAYS USED TO TEST THE FIRST 30 REFERENCE CHEMICALS, ATLA. Alternatives to laboratory animals, 24, 1996, pp. 251-272
MEIC EVALUATION OF ACUTE SYSTEMIC TOXICITY .2. IN-VITRO RESULTS FROM 68 TOXICITY ASSAYS USED TO TEST THE FIRST 30 REFERENCE CHEMICALS AND ACOMPARATIVE CYTOTOXICITY ANALYSIS
Authors: CLEMEDSON C MCFARLANEABDULLA E ANDERSSON M BARILE FA CALLEJA MC CHESNE C CLOTHIER R COTTIN M CURREN R DIERICKX P FERRO M FISKESJO G GARZAOCANAS L GOMEZLECHON MJ GULDEN M ISOMAA B JANUS J JUDGE P KAHRU A KEMP RB KERSZMAN G KRISTEN U KUNIMOTO M KARENLAMPI S LAVRIJSEN K LEWAN L LILIUS H MALMSTEN A OHNO T PERSOONE G PETTERSSON R ROGUET R ROMERT L SANDBERG M SAWYER TW SEIBERT H SHRIVASTAVA R SJOSTROM M STAMMATI A TANAKA N TORRESALANIS O VOSS JU WAKURI S WALUM E WANG XH ZUCCO F EKWALL B
Citation: C. Clemedson et al., MEIC EVALUATION OF ACUTE SYSTEMIC TOXICITY .2. IN-VITRO RESULTS FROM 68 TOXICITY ASSAYS USED TO TEST THE FIRST 30 REFERENCE CHEMICALS AND ACOMPARATIVE CYTOTOXICITY ANALYSIS, ATLA. Alternatives to laboratory animals, 24, 1996, pp. 273-311
REDUCTION OF THE PRODRUG LOPERAMIDE OXIDE TO ITS ACTIVE-DRUG LOPERAMIDE IN THE GUT OF RATS, DOGS, AND HUMANS
Authors: LAVRIJSEN K VANDYCK D VANHOUDT J HENDRICKX J MONBALIU J WOESTENBORGHS R MEULDERMANS W HEYKANTS J
Citation: K. Lavrijsen et al., REDUCTION OF THE PRODRUG LOPERAMIDE OXIDE TO ITS ACTIVE-DRUG LOPERAMIDE IN THE GUT OF RATS, DOGS, AND HUMANS, Drug metabolism and disposition, 23(3), 1995, pp. 354-362
THE METABOLISM AND EXCRETION OF RISPERIDONE AFTER ORAL-ADMINISTRATIONIN RATS AND DOGS
Authors: MEULDERMANS W HENDRICKX J MANNENS G LAVRIJSEN K JANSSEN C BRACKE J LEJEUNE L LAUWERS W HEYKANTS J
Citation: W. Meuldermans et al., THE METABOLISM AND EXCRETION OF RISPERIDONE AFTER ORAL-ADMINISTRATIONIN RATS AND DOGS, Drug metabolism and disposition, 22(1), 1994, pp. 129-138
THE METABOLIC CONVERSION OF THE PRO-DRUG LOPERAMIDE OXIDE TO LOPERAMIDE IN-VITRO AND IN-VIVO
Authors: LAVRIJSEN K MONBALIU J VANBEIJSTERVELDT L WOESTENBORGHS R MEULDERMANS W VERLINDEN M HEYKANTS J
Citation: K. Lavrijsen et al., THE METABOLIC CONVERSION OF THE PRO-DRUG LOPERAMIDE OXIDE TO LOPERAMIDE IN-VITRO AND IN-VIVO, Gastroenterology, 106(4), 1994, pp. 10000246-10000246
A PREDICTIVE MODEL FOR SUBSTRATES OF CYTOCHROME P450-DEBRISOQUINE (2D6)
Authors: KOYMANS L VERMEULEN NPE VANACKER SABE TEKOPPELE JM HEYKANTS JJP LAVRIJSEN K MEULDERMANS W DENKELDER GMD
Citation: L. Koymans et al., A PREDICTIVE MODEL FOR SUBSTRATES OF CYTOCHROME P450-DEBRISOQUINE (2D6), Chemical research in toxicology, 5(2), 1992, pp. 211-219
Risultati: 1-7 |